{"id":"W4255248028","doi":"10.2165/00128413-200515060-00058","title":"Cetuximab [Erbitux; Bristol-Myers Squibb, ImClone Systems] injection has been approved by Health Canada's Biologics and Genetic Therapeutics Directorate","year":2005,"lang":"en","type":"article","venue":"Inpharma Weekly","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Medicine; Bristol-Myers; Cetuximab; Family medicine; Pharmacy; Pharmacology; Internal medicine; Cancer","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009292813,0.000320196,0.0004328637,0.0005003433,0.0006959563,0.001118211,0.0005240196,0.000668551,0.0776055],"category_scores_gemma":[0.00156143,0.0002422966,0.0002645063,0.0003865059,0.0004264181,0.0003156421,0.0003045753,0.0009531775,0.01401231],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002996794,"about_ca_system_score_gemma":0.008723989,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.07138503,"about_ca_topic_score_gemma":0.1858834,"domain_scores_codex":[0.9994926,0.00007394351,0.00001970912,0.00004508134,0.0002739671,0.00009472702],"domain_scores_gemma":[0.9990885,0.00009484027,0.00007150506,0.00005661189,0.000454109,0.0002344849],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003991393,0.0007148228,0.005971517,0.0002931221,0.00009454915,0.0003289765,0.0001043377,0.0006372215,0.01639658,0.009068693,0.527159,0.4352398],"study_design_scores_gemma":[0.001200427,0.001011063,0.03043952,0.0001487902,0.0001208801,0.0005793873,0.00004614939,0.00204416,0.01859174,0.0004797366,0.9453108,0.00002717058],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.09386753,0.01199193,0.009027215,0.02168638,0.003326321,0.00164078,0.02088336,0.002856357,0.8347202],"genre_scores_gemma":[0.1857618,0.003195072,0.005332513,0.002246496,0.0003908782,0.000148063,0.008085967,0.0002407885,0.7945984],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.928615,"threshold_uncertainty_score":0.2596163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2486589550439336,"score_gpt":0.375657940229696,"score_spread":0.1269989851857624,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}